Skip to main content
Premium Trial:

Request an Annual Quote

Einstein College of Medicine Lands $9.5M for Diabetes Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has given the Albert Einstein College of Medicine of Yeshiva University nearly $10.2 million through two new grants to fund its Diabetes Research and Training Center (DRTC), which conducts genetics and molecular research, among other disciplines.

The DRTC has six cores, including ones focused on epigenomics, metabolomics, flow cytometry, animal physiology, analytical imaging, and hormone assay research.

In addition to the five-year, $9.5 million grant from the National Institute of Digestive and Kidney Diseases, the new funding includes a $632,000 supplemental grant for equipment and pilot and feasibility studies awarded through the American Recovery and Reinvestment Act.

"The ultimate goal of these studies is to develop new therapies for the prevention or treatment of diabetes," Jeffrey Pessin, director of the DRTC and a professor of medicine and of molecular pharmacology at Einstein, said in a statement.

Some of the DRTC's research efforts are conducted at the Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion, a 223,000-square-feet facility that was completed in 2008 at Yeshiva's campus in Bronx, NY.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.